Pacira has filed a lawsuit so it can restore promoting its postoperative pain drug Exparel for different surgeries. The FDA has sent them a letter of warning to stop promoting off-label uses, which is something that the company strongly denies.
Pacira has filed a lawsuit so it can restore promoting its postoperative pain drug Exparel for different surgeries. The FDA has sent them a letter of warning to stop promoting off-label uses, which is something that the company strongly denies.
Share this Article
Recommended